Go Search Go Contents Go to bottom site map

S. Korea's drug watchdog halts sales of Pfizer's antibiotic

2013/10/02 12:06

SEOUL, Oct. 2 (Yonhap) -- South Korea's drug watchdog said Wednesday that it has suspended the sales of Pfizer's antibiotic azithromycin, sold as Zithromax, for three months due to inaccurate dosage information on its local product labels.

The latest move by the Ministry of Food and Drug Safety is in addition to its earlier recall order on Pfizer Pharmaceutical Korea, the local unit of Pfizer Inc., for its Zithromax 900-milligram dry syrup sold here.